UNICA IRIS Institutional Research Information System

CADEDDU DESSALVI, CHRISTIAN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 313.135
NA - Nord America 13.012
AS - Asia 6.037
AF - Africa 1.109
SA - Sud America 911
Continente sconosciuto - Info sul continente non disponibili 717
OC - Oceania 57
Totale 334.978
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 309.867
US - Stati Uniti d'America 12.725
SG - Singapore 2.168
CN - Cina 1.768
ZA - Sudafrica 814
UA - Ucraina 768
BR - Brasile 709
SE - Svezia 696
VN - Vietnam 562
GB - Regno Unito 381
FI - Finlandia 364
IN - India 353
DE - Germania 338
FR - Francia 302
BD - Bangladesh 242
HK - Hong Kong 202
CA - Canada 157
KR - Corea 91
NL - Olanda 71
AR - Argentina 69
KE - Kenya 65
TR - Turchia 64
PK - Pakistan 62
BE - Belgio 56
IQ - Iraq 52
JP - Giappone 51
SA - Arabia Saudita 49
ID - Indonesia 48
MX - Messico 48
RU - Federazione Russa 48
PH - Filippine 47
ES - Italia 46
ZM - Zambia 44
AT - Austria 42
PL - Polonia 41
MY - Malesia 31
NP - Nepal 31
AU - Australia 28
AE - Emirati Arabi Uniti 27
UG - Uganda 27
UZ - Uzbekistan 26
CO - Colombia 25
EC - Ecuador 25
MA - Marocco 24
CL - Cile 23
IR - Iran 19
TN - Tunisia 19
VE - Venezuela 19
EG - Egitto 17
LK - Sri Lanka 15
NG - Nigeria 15
TH - Thailandia 15
GH - Ghana 14
JM - Giamaica 13
PY - Paraguay 13
TW - Taiwan 13
FJ - Figi 12
KH - Cambogia 12
KW - Kuwait 12
PE - Perù 12
BG - Bulgaria 11
IE - Irlanda 11
JO - Giordania 11
TZ - Tanzania 11
MW - Malawi 10
PT - Portogallo 10
RO - Romania 10
CU - Cuba 9
DZ - Algeria 9
ZW - Zimbabwe 9
KZ - Kazakistan 8
LT - Lituania 8
NZ - Nuova Zelanda 8
OM - Oman 8
TT - Trinidad e Tobago 8
AL - Albania 7
AZ - Azerbaigian 7
EU - Europa 7
IL - Israele 7
NO - Norvegia 7
BO - Bolivia 6
CH - Svizzera 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
HR - Croazia 6
LC - Santa Lucia 6
QA - Qatar 6
UY - Uruguay 6
CY - Cipro 5
GR - Grecia 5
GT - Guatemala 5
HN - Honduras 5
LV - Lettonia 5
PG - Papua Nuova Guinea 5
PR - Porto Rico 5
SY - Repubblica araba siriana 5
AM - Armenia 4
BH - Bahrain 4
Totale 334.181
Salva come PNG Salva come JPEG
Città #
Cagliari 213.977
Uta 95.140
Fairfield 1.109
Ashburn 1.098
Singapore 1.082
Woodbridge 947
Dallas 756
Houston 654
San Jose 652
Chandler 620
Ann Arbor 564
Boardman 533
Wilmington 489
Nyköping 452
Seattle 431
Jacksonville 405
Cambridge 391
Beijing 354
Dearborn 246
Los Angeles 229
Council Bluffs 223
Helsinki 216
Johannesburg 211
Santa Clara 205
Hong Kong 179
The Dalles 167
Nanjing 161
Ho Chi Minh City 155
Lauterbourg 155
New York 135
Boston 125
Hefei 114
Hanoi 108
Buffalo 99
Shanghai 93
Dong Ket 90
Seoul 85
Cape Town 78
Pretoria 72
San Diego 69
Toronto 67
Guangzhou 64
São Paulo 64
Orem 58
London 57
Milan 57
Columbus 50
Nanchang 49
Redwood City 49
Tianjin 49
Atlanta 48
Shenyang 46
Chicago 45
Chennai 44
Lusaka 42
Munich 42
Phoenix 41
Tokyo 41
Frankfurt am Main 39
Rome 38
Hebei 37
Changsha 36
Durban 35
Brooklyn 34
Dhaka 33
Amsterdam 32
Brussels 32
Da Nang 32
Montreal 32
Nairobi 32
Nuremberg 30
Denver 29
Mumbai 28
Orange 27
Warsaw 26
Jiaxing 25
Jinan 25
Redondo Beach 25
Mountain View 22
Belo Horizonte 21
Lappeenranta 20
Manchester 20
Norwalk 20
Rio de Janeiro 20
Tashkent 20
Zhengzhou 20
Auburn Hills 19
Pune 19
San Francisco 19
Vienna 19
Washington 19
Baghdad 18
Sassari 18
Ankara 17
Haiphong 17
Kunming 17
Quito 17
Stockholm 17
Turku 16
Verona 16
Totale 324.820
Salva come PNG Salva come JPEG
Nome #
Non-invasive estimation of stroke volume during exercise from oxygen in heart failure patients 75.125
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers 12.926
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 4.380
Metabolomic approach to profile functional and metabolic changes in heart failure 4.238
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.186
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.947
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.586
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.569
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 3.544
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.479
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.415
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 3.376
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 3.355
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 3.134
Metabolomics and heart failure: a new and promising scientific approach 2.999
Coronary Artery Disease 2.939
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 2.848
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.834
Sex-related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model 2.771
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.762
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.753
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.716
Metabolomics, a promising approach to translational research in cardiology 2.696
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.554
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 2.496
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 2.422
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.418
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 2.330
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.313
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 2.286
Women-specific predictors of cardiovascular disease risk - new paradigms 2.264
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.255
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 2.245
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 2.222
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 2.198
null 2.190
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 2.181
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2.180
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.167
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 2.121
Antineoplastic drug-induced cardiotoxicity: A redox perspective 2.107
The need of a gender-corrected evidence based medicine 2.083
Gender differences in the development of cardiac complications: A multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac follow-up 1.996
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens 1.991
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.973
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.946
Ultrasound examination for the detection of simulated periapical bone lesions in bovine mandibles: an ex vivo study 1.940
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.934
A novel desmoplakin mutation associated with left dominant arrhythmogenic cardiomyopathy and cutaneous phenotype 1.918
Current views on anthracycline cardiotoxicity 1.913
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.886
Arterial hypertension in the female world: Pathophysiology and therapy 1.880
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.875
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.836
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.795
Multimodality imaging diagnosis of multiple ventricular thrombosis and massive stroke after gemcitabine and cisplatin chemotherapy for Urothelial Cancer 1.789
Gender differences in cardiology: is it time for new guidelines? 1.769
Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies 1.768
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.735
Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib 1.721
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.706
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 1.686
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.675
Role of biomarkers in monitoring antiblastic cardiotoxicity 1.639
Evaluation of left atrial appendage function and thrombi in patients with atrial fibrillation: from transthoracic to real time 3D transesophageal echocardiography 1.600
Subclinical contractility impairment in HIV-infected patients: Dependence on the class of antiretroviral drugs 1.586
High prevalence of interatrial septal aneurysm in young adults who were born preterm 1.585
Subclinical contractility impairment in HIV-infected patients varies according to class of antiretroviral drugs 1.574
Vascular damage-Coronary artery disease 1.561
The different role of sex hormones on female cardiovascular physiology and function: not only oestrogens 1.527
Diastolic Function in Systemic Sclerosis Patients: A Neglected Issue? 1.523
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.516
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 1.506
null 1.489
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.484
Antiinflammatory therapy with canakinumab for atherosclerotic disease 1.482
Trastuzumab-induced early cardiac dysfunction assessed by speckle tracking echocardiography: correlation with chronic inflammation and oxidative stress markers 1.472
null 1.471
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: Role of echocardiography 1.459
Early Ventricular Dysfunction in Type II Diabetes: Role of Metabolic Unbalance 1.423
Altered transmural contractility in women affected by cardiac X syndrome 1.413
Metabolomics: a new era in cardiology? 1.363
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry 1.354
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.329
Time-to-balloon dependence of coronary flow velocity reserve after primary angioplasty in patients with anterior acute myocardial infarction 1.327
Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects 1.313
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology 1.290
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.287
Consensus: Screening e terapia della cardiopatia ischemica nel paziente diabetico 1.268
null 1.234
Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate 1.213
Significant QT interval prolongation and long QT in young adult ex-preterm newborns with extremely low birth weight 1.196
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.183
Relationship between high values of HOMA-IR and cardiovascular response to metformin 1.153
Mortality for pancreatic cancer among aluminium smelter workers in Sardinia, Italy 1.141
null 1.054
Trastuzumab induced-early cardiac disfunction assessed with TDI: correlation with biological markers of chronic inflammation and oxidative stress. 1.051
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 1.048
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 996
Gender differences in heart rate variability among patients affected by Parkinson's disease 977
Totale 289.429
Salva come PNG Salva come JPEG
Categoria #
all - tutte 407.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 407.120
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210.089 0 722 575 1.132 887 739 551 701 1.216 1.068 1.201 1.297
2022/202316.778 1.663 2.553 2.364 1.487 1.426 1.398 717 1.151 1.126 885 1.277 731
2023/202419.141 981 726 751 1.407 1.973 3.243 3.007 1.263 1.173 1.249 1.714 1.654
2024/2025130.294 9.143 11.685 81.569 18.133 2.082 3.510 2.373 226 443 270 360 500
2025/202612.219 648 513 1.387 975 968 1.049 2.260 922 940 1.187 686 684
2026/2027855 291 564 0 0 0 0 0 0 0 0 0 0
Totale 334.978